Heather McArthur
希瑟·麦克阿瑟
MD, MPH
Clinical Director, Breast Oncology Program乳腺肿瘤项目临床主任
👥Biography 个人简介
Heather McArthur is a leading investigator in immunotherapy for early-stage TNBC at Cedars-Sinai. Her trials have defined the role of checkpoint inhibitors in neoadjuvant and adjuvant settings, and she is a prominent advocate for patient-centered breast cancer care.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Immunotherapy in Early TNBC
Led investigator-initiated trials of checkpoint inhibitors in neoadjuvant TNBC, elucidating biomarkers of immune response and optimizing combination regimens.
Translational Immunology in Breast Cancer
Advanced understanding of immune contexture and tumor microenvironment dynamics in TNBC, linking translational findings to clinical trial design.
Representative Works 代表性著作
Neoadjuvant pembrolizumab plus chemotherapy in early TNBC
Annals of Oncology (2020)
Demonstrated improved pCR with pembrolizumab-containing neoadjuvant therapy, supporting immunotherapy integration in early TNBC.
Immune biomarkers of response to checkpoint inhibition in TNBC
Journal of Immunotherapy of Cancer (2021)
Identified predictive immune signatures guiding patient selection for checkpoint inhibitor therapy in triple-negative breast cancer.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
关注 希瑟·麦克阿瑟 的研究动态
Follow Heather McArthur's research updates
留下邮箱，当我们发布与 Heather McArthur（Cedars-Sinai Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment